Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016:2016:2769735.
doi: 10.1155/2016/2769735. Epub 2016 Jan 3.

Neuroplasticity and Repair in Rodent Neurotoxic Models of Spinal Motoneuron Disease

Rosario Gulino  1
Affiliations
Review

Neuroplasticity and Repair in Rodent Neurotoxic Models of Spinal Motoneuron Disease

Rosario Gulino. Neural Plast. 2016.

Abstract

Retrogradely transported toxins are widely used to set up protocols for selective lesioning of the nervous system. These methods could be collectively named "molecular neurosurgery" because they are able to destroy specific types of neurons by using targeted neurotoxins. Lectins such as ricin, volkensin, or modeccin and neuropeptide- or antibody-conjugated saporin represent the most effective toxins used for neuronal lesioning. Some of these specific neurotoxins could be used to induce selective depletion of spinal motoneurons. In this review, we extensively describe two rodent models of motoneuron degeneration induced by volkensin or cholera toxin-B saporin. In particular, we focus on the possible experimental use of these models to mimic neurodegenerative diseases, to dissect the molecular mechanisms of neuroplastic changes underlying the spontaneous functional recovery after motoneuron death, and finally to test different strategies of neural repair. The potential clinical applications of these approaches are also discussed.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Proposed model of spontaneous SC plasticity after motoneuron degeneration.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Ajroud-Driss S., Siddique T. Sporadic and hereditary amyotrophic lateral sclerosis (ALS) Biochimica et Biophysica Acta—Molecular Basis of Disease. 2015;1852(4):679–684. doi: 10.1016/j.bbadis.2014.08.010. - DOI - PubMed
    1. Tandan R., Bradley W. G. Amyotrophic lateral sclerosis: part I. Clinical features, pathology, and ethical issues in management. Annals of Neurology. 1985;18(3):271–280. doi: 10.1002/ana.410180302. - DOI - PubMed
    1. Tandan R., Bradley W. G. Amyotrophic lateral sclerosis: part 2. Etiopathogenesis. Annals of Neurology. 1985;18(4):419–431. doi: 10.1002/ana.410180402. - DOI - PubMed
    1. Bento-Abreu A., Van Damme P., Van Den Bosch L., Robberecht W. The neurobiology of amyotrophic lateral sclerosis. The European Journal of Neuroscience. 2010;31(12):2247–2265. doi: 10.1111/j.1460-9568.2010.07260.x. - DOI - PubMed
    1. Aizawa H., Sawada J., Hideyama T., et al. TDP-43 pathology in sporadic ALS occurs in motor neurons lacking the RNA editing enzyme ADAR2. Acta Neuropathologica. 2010;120(1):75–84. doi: 10.1007/s00401-010-0678-x. - DOI - PubMed

LinkOut - more resources